Spots Global Cancer Trial Database for metastatic cholangiocarcinoma
Every month we try and update this database with for metastatic cholangiocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors | NCT02757391 | Colorectal Aden... Metastatic Chol... Metastatic Colo... Metastatic Dige... Metastatic Esop... Metastatic Gast... Metastatic Panc... Stage IV Colore... Stage IV Esopha... Stage IV Gastri... Stage IV Pancre... Stage IVA Color... Stage IVB Color... | Adoptive Immuno... Aldesleukin Cyclophosphamid... Laboratory Biom... Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma | NCT03250273 | Metastatic Chol... Cholangiocarcin... Pancreatic Canc... Metastatic Panc... Unresectable Pa... Unresectable Ch... | Entinostat Nivolumab Entinostat Nivolumab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma | NCT04088188 | Advanced Cholan... Metastatic Chol... Unresectable Ch... | Cisplatin Gemcitabine Ivosidenib Pemigatinib | 18 Years - | Academic and Community Cancer Research United | |
| NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma | NCT06420349 | Advanced Cholan... Metastatic Chol... Refractory Chol... Stage III Hilar... Stage III Intra... Stage IV Hilar ... Stage IV Intrah... | Biospecimen Col... Computed Tomogr... Heat Shock Fact... Magnetic Resona... Positron Emissi... Ultrasound-Guid... | 18 Years - | Mayo Clinic | |
| Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver | NCT04175912 | Metastatic Chol... Metastatic Hepa... Stage III Hepat... Stage III Intra... Stage IIIA Hepa... Stage IIIA Intr... Stage IIIB Hepa... Stage IIIB Intr... Stage IV Hepato... Stage IV Intrah... Stage IVA Hepat... Stage IVB Hepat... Unresectable Ch... Unresectable He... Unresectable In... | Carboplatin Paclitaxel Pevonedistat | 18 Years - | National Cancer Institute (NCI) | |
| Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations | NCT04087876 | Intrahepatic Ch... | derazantinib | 18 Years - | Basilea Pharmaceutica | |
| A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma | NCT03656536 | Unresectable Ch... Metastatic Chol... | Pemigatinib Gemcitabine Cisplatin | 18 Years - | Incyte Corporation | |
| Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma | NCT06178588 | Locally Advance... Metastatic Chol... Recurrent Chola... Stage III Hilar... Stage III Intra... Stage IV Hilar ... Stage IV Intrah... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Positron Emissi... Sacituzumab Gov... | 18 Years - | University of Kansas Medical Center | |
| A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma | NCT03656536 | Unresectable Ch... Metastatic Chol... | Pemigatinib Gemcitabine Cisplatin | 18 Years - | Incyte Corporation | |
| NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma | NCT06420349 | Advanced Cholan... Metastatic Chol... Refractory Chol... Stage III Hilar... Stage III Intra... Stage IV Hilar ... Stage IV Intrah... | Biospecimen Col... Computed Tomogr... Heat Shock Fact... Magnetic Resona... Positron Emissi... Ultrasound-Guid... | 18 Years - | Mayo Clinic | |
| Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) | NCT02989857 | Advanced Cholan... Metastatic Chol... | AG-120 Placebo | 18 Years - | Servier | |
| A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion | NCT04238715 | Cholangiocarcin... | E7090 | 20 Years - | Eisai Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
